MWM
ABBV icon

MOKAN Wealth Management’s AbbVie ABBV Stock Holding History

MOKAN Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6M Buy
23,835
+4,668
+24% +$1M 2.29% 14
2026
Q1 		$4.17M Sell
19,167
-1,162
-6% -$258K 1.84% 16
2025
Q4 		$4.64M Buy
20,329
+2,134
+12% +$486K 2.06% 14
2025
Q3 		$4.21M Sell
18,195
-102
-0.6% -$20.8K 2.12% 13
2025
Q2 		$3.4M Buy
18,297
+3,236
+21% +$601K 1.9% 16
2025
Q1 		$3.16M Sell
15,061
-973
-6% -$189K 1.9% 17
2024
Q4 		$2.85M Buy
+16,034
New +$2.95M 1.81% 17

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MOKAN Wealth Management's ABBV Position: Q2 2026 in Review

MOKAN Wealth Management increased its AbbVie (ABBV) stake by 24% in Q2 2026, buying an estimated $1M and bringing the position to 23,835 shares worth $6M. The position accounts for 2.29% of the portfolio, ranked #14.

MOKAN Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,132 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MOKAN Wealth Management held 23,835 shares of AbbVie worth $6M as of Q2 2026.
  • MOKAN Wealth Management bought 4,668 AbbVie shares in Q2 2026, an estimated $1M.
  • AbbVie made up 2.29% of MOKAN Wealth Management's portfolio in Q2 2026, its #14 holding.
  • MOKAN Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,132 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MOKAN Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.